Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folinic Acid Intervention for ASD
NCT01602016Phase 2Terminated
- Sponsor
- University of Arkansas
- Start
- May 2012
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of folinic acid in Autism Spectrum Disorder (ASD), sponsored by University of Arkansas. Started May 2012; status: terminated.
02
Drugs
folinic acid
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01602016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602016.